2016 International Congress Archives - Page 6 of 207

GAA expansion with clinic/urodynamic findings in Friedreich’s ataxia with LUTS

P.N.S. Almeida, A.F.A. Musegante, U. Barroso (Salvador, Brazil)
Gait and anthropometric characteristics of patients with Parkinson’s disease seen in a Nigerian tertiary hospital

A.O. Ogundele, M.O. Olaogun, M.A. Komolafe (Ile-Ife, Nigeria)
Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease

R. Morris, S. Lord, J. Bunce, D. Burn, L. Rochester (Newcastle-Upon-Tyne, United Kingdom)
Gait impairment is more than a motor symptom in Parkinson’s disease

H.F. Chan, D.K.W. Chau, T. Fung, Y.F. Cheung, W.C. Fong (Hong Kong, Hong Kong)
Gait initiation in response to emotion-inducing pictures in Parkinson’s disease

L. Avanzino, G. Lagravinese, A. Ravaschio, E. Pelosin, G. Abbruzzese (Genoa, Italy)
GAITRite comparison between Parkinson’s disease stages

W. Deeb, D. Martinez-Ramirez, J. Giugni, M. Okun, C. Hass (Gainesville, FL, USA)
Gastrointestinal non-motor symptoms in PD: Correlation between objective markers and subjective symptoms

K. Knudsen, T. Fedorova, K. Østergaard, K. Krogh, P. Borghammer (Aarhus C., Denmark)
Gaze evoked blepharospasm

P.P. Urban (Hamburg, Germany)
Gender and age-based differential item functioning (DIF) analysis of MDS-UPDRS

C.G. Goetz, L. Wang, G.T. Stebbins, B.C. Tilley, S. Luo (Chicago, IL, USA)
Gender differences in DLB: frequency, clinical presentation and treatment

S. Garcia-Ptacek, M.G. Kramberger, D. Aarsland (Huddinge, Sweden)
Gender differences in heart rate variability among patients affected by Parkinson’s disease

P. Solla, E. Erriu, C. Cadeddu, L. Cugusi, G. Costantini, S. Nieddu, M.R. Aresu, R. Farris, M. Meloni, D. Fonti, G. Mercuro, F. Marrosu (Monserrato (Cagliari), Italy)
Gender effect on non-motor symptoms in Parkinson’s disease: Are men more at risk for most of them?

R. Vasta, A. Nicoletti, G. Mostile, G. Nicoletti, G. Arabia, G. Iliceto, P. Lamberti, R. Marconi, L. Morgante, P. Barone, A. Quattrone, M. Zappia (Catania, Italy)
Gender-age features of autonomic heart rhythm disturbances in Parkinson’s disease patients

I. Solodovnikova (Odessa, Ukraine)
Gender-dependent behavioral and biochemical differences in the A53T genetic mouse model of Parkinson’s disease

G. Costa, M.J. Sisalli, L. Contu, A. Scorziello, M. Morelli (Cagliari, Italy)
Gene delivery of AAV2-neurturin for patients with Parkinson’s disease: A meta-analysis

A.G. Almraezy, H. Ahmed, M. Elnenny, A. Negida (Cairo, Egypt)
Gene expression analysis using the Parkinson’s disease map reveals early effects of alpha-synuclein on PD pathogenesis

S. Gebel, A. Ashrafi, P. Garcia, M. Ostaszewski, P. Gawron, L. Vallar, N. Nicot, T. Kaoma, R. Balling, E. Glaab, M. Buttini (Esch-sur-Alzette, Luxembourg)
Gene network driven probable drug target identification: An in-silico study on Parkinson’s disease

H.N. Singh, J. Pani, K.G. Singh, V. Swarup (Gautam Budh Nagar, India)
Generation and characterization of iPSC-derived nigral dopaminergic and pyramidal glutamatergic neurons from patients affected by multiple system atrophy

G. Monzio Compagnoni, E. Frattini, S. Salani, F. Fortunato, N. Bresolin, S. Corti, G.P. Comi, A. Di Fonzo (Milan, Italy)
Generation and characterization of midbrain organoids from iPSCs of familial Parkinson’s disease

E. Frattini, G. Monzio Compagnoni, S. Salani, P. Rinchetti, M. Nizzardo, M. Baccarin, N. Bresolin, G.P. Comi, S.P. Corti, A. Di Fonzo (Milan, Italy)
Generation of dopaminergic neurons for studying Parkinson’s disease using patient blood cells

D. Ma, W. Zhou, Y. Chao, Y. Zhao, E.K. Tan (Singapore, Singapore)
Generation of human induced pluripotent stem cells carrying a safety bet for cell-based therapy in Parkinson’s disease

Y. Kimura, Y. Kanemura, T. Shofuda, M. Onodera, M. Oda, M. Nakamori, T. Nakano, H. Mochizuki (Osaka, Japan)
Genetic analysis of CHCHD2 gene in Parkinson’s disease in a Taiwanese population

T.S. Fan, H.I. Lin, C.H. Lin, R.M. Wu (Taipei, Taiwan)
Genetic analysis of eighty-seven multiple system atrophy patients

G. Franco, D. Ronchi, I. Trezzi, L. Borellini, F. Del Sorbo, B. Garavaglia, A.E. Elia, G. Ardolino, G. Mora, S. Bonato, N. Bresolin, G.P. Comi, A. Di Fonzo (Milan, Italy)
Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson’s disease

I. Huertas Fernandez, S. Jesus, F.J. Garcia Gomez, J.A. Lojo, I. Bernal Bernal, M. Bonilla Toribio, J.F. Martin Rodriguez, D. Garcia Solis, P. Gomez Garre, P. Mir (Sevilla, Spain)
Genetic Identification of early-onset parkinsonism among Norwegian patients

E.K. Gustavsson, J. Trinh, M. McKenzie, S. Bortnick, J.O. Aasly, M.J. Farrer (Vancouver, BC, Canada)
Genetic risk factors of dementia and psychosis in Parkinson’s disease

T. Oeda, A. Umemura, Y. Mori, S. Tomita, M. Kohsaka, K. Park, K. Inoue, H. Fujimura, H. Hasegawa, H. Sugiyama, H. Sawada (Kyoto, Japan)
Genetic risk of Parkinson’s disease in the general population

S. Darweesh, V. Verlinden, H. Adams, A. Uitterlinden, A. Hofman, B. Stricker, C. van Duijn, P. Koudstaal, M.A. Ikram (Rotterdam, Netherlands)
Genetic variation near the SNCA gene associates with Parkinson’s disease motor phenotype and progression

C. Cooper, Y. Berlyand, D. Weintraub, S.X. Xie, A. Espay, J. Quinn, K. Edwards, T. Montine, C. Zabetian, A. Chen-Plotkin (Philadelphia, PA, USA)
Genome-wide bioinformatic analysis of Parkinson’s disease: A focus on neuronal health maintenance

R. Qadri, M.A. Faiq, V. Goyal, A.K. Mukhopadhyay (New Delhi, India)
Glatiramir acetate (Copaxone) causes restoration of the striatal dopamine in a progressive MPTP mouse model of Parkinson’s disease

C.K. Meshul, M.J. Churchill (Portland, OR, USA)
Glial cells and iron accumulation in the brain of the Zitter rat

T. Kadowaki, H. Lassmann, S. Ueda, C. Schuh, K. Hirata (Mibu, Japan)
Global implementation of efficacious voice treatment for Parkinson’s disease: LSVT LOUD: Germany®

T. Brauer, H. Penner, P. Benecke, C. Fox, L. Ramig (Mainz, Germany)
Globus pallidus interna oscillatory activity differentiates tics from voluntary movements and the Parkinsonian resting state

J. Jimenez-Shahed, I. Telkes, A. Viswanathan, N.F. Ince (Houston, TX, USA)
Glucagon-like peptide 1 analogues for treating multiple system atrophy: A translational study

F. Bassil, M.H. Canron, A. Vital, E. Bezard, Y. Li, N.H. Greig, P.O. Fernagut, W.G. Meissner (Bordeaux, France)
Glucocerebrosidase activity in a cohort of PD patients

I. Trezzi, V. Melzi, G. Franco, L. Borellini, E. Monfrini, A. Bordoni, N. Bresolin, G.P. Comi, A. Di Fonzo (Milan, Italy)
Glutathione status in Parkinson’s disease

L.K. Mischley (Kenmore, WA, USA)
Gray/white matter contrast loss correlates with clinical severity and visuospatial impairment in Parkinson’s disease patients

C. Uribe, B. Segura, H.C. Baggio, M.J. Marti, F. Valldeoriola, Y. Compta, A.I. Garcia-Diaz, A. Campabadal, A. Abos, C. Junque (Barcelona, Spain)
Greater incidence of depressive symptoms in atypical parkinsonism: Importance of early screening

L. Almeida, B. Ahmed, R. Walz, S. De Jesus, A. Patterson, D. Martinez-Ramirez, D. Vaillancourt, D. Bowers, H. Ward, M.S. Okun, M. Armstrong, N. McFarland (Gainesville, FL, USA)
Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)

M. Chondrogiorgi, L.G. Astrakas, A.K. Zikou, M.I. Argyropoulou, S. Konitsiotis (Ioannina, Greece)
Group climate in the voice therapy of patients with Parkinson’s disease

G.L.A. Diaféria, P.B. Takaki, G. Madazio, C. Pacheco, M.S. Behlau (São Paulo, Brazil)
Group meetings for newly diagnosed Parkinson’s disease patients and their spouses: A preliminary experience

N. Geva, A. Hilel, Y. Manor, S. Arad, A. Ezra, N. Giladi, T. Gurevich (Tel Aviv, Israel)
Gustatory function of patients with essential tremor and its correlation with olfactory and cognitive functions

M.G. Senol, H. Tekeli, M. Saglam, E. Arslanoglu (Istanbul, Turkey)